-
1 Comment
Elixinol Global Limited is currently in a long term downtrend where the price is trading 37.6% below its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.2.
Finally, its free cash flow grew by 50.0% to $-4M since the same quarter in the previous year.
Based on the above factors, Elixinol Global Limited gets an overall score of 2/5.
ISIN | AU000000EXL4 |
---|---|
Exchange | F |
CurrencyCode | EUR |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Market Cap | 3M |
---|---|
Beta | 2.41 |
PE Ratio | None |
Target Price | None |
Dividend Yield | None |
Elixinol Wellness Limited, a holding company, provides healthy products in Australia, the Americas, and internationally. The company provides human nutrition, human wellness, pet wellness, and superfood ingredients under Hemp Foods Australia, Mt Elephant, The Healthy Chef, Soul Foods, Ananda Equine, and Field Day brands. It distributed through grocery, wholesale, and e-commerce channels for white label customers, as well as food, beverage, and beauty manufacturers. In addition, the company engages in the development, sourcing, marketing, and distribution of hemp-derived CBD products, including skincare. The company was formerly known as Elixinol Global Limited and changed its name to Elixinol Wellness Limited in May 2021. The company was incorporated in 2017 and is headquartered in South Melbourne, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for E8M.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025